Diagnostic Value of Transluminal Attenuation Gradient for the Presence of Ischemia as Defined by Fractional Flow Reserve and Quantitative Positron Emission Tomography.


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
02 2019
Historique:
received: 23 08 2017
revised: 05 10 2017
accepted: 05 10 2017
pubmed: 19 12 2017
medline: 14 1 2020
entrez: 18 12 2017
Statut: ppublish

Résumé

The aim of this study was to investigate the incremental diagnostic value of transluminal attenuation gradient (TAG), TAG with corrected contrast opacification (TAG-CCO), and transluminal diameter gradient (TDG) over coronary computed tomography angiography (CTA)-derived diameter stenosis alone for the identification of ischemia as defined by both the invasive reference standard fractional flow reserve (FFR) and the noninvasive reference standard quantitative positron emission tomography (PET). In addition to anatomic information obtained by coronary CTA, several functional CT parameters have been proposed to identify hemodynamically significant lesions more accurately, such as TAG, TAG-CCO, and more recently TDG. However, clinical validation studies have reported conflicting results, and a recent study has suggested that TAG may be affected by changes in vessel diameter. Patients with suspected coronary artery disease underwent coronary CTA and [ A total of 557 (91.9%) coronary arteries of 201 patients were included for analysis. TAG, TAG-CCO, and TDG did not discriminate between vessels with or without ischemia as defined by either PET or FFR. Furthermore, these parameters did not have incremental diagnostic accuracy over coronary CTA alone for the presence of ischemia as defined by PET and FFR. There was a significant correlation between TDG and TAG (r = 0.47; p < 0.001) and between TDG and TAG-CCO (r = 0.37; p < 0.001). TAG, TAG-CCO, and TDG do not provide incremental diagnostic value over coronary CTA alone for the presence of ischemia as defined by [

Sections du résumé

OBJECTIVES
The aim of this study was to investigate the incremental diagnostic value of transluminal attenuation gradient (TAG), TAG with corrected contrast opacification (TAG-CCO), and transluminal diameter gradient (TDG) over coronary computed tomography angiography (CTA)-derived diameter stenosis alone for the identification of ischemia as defined by both the invasive reference standard fractional flow reserve (FFR) and the noninvasive reference standard quantitative positron emission tomography (PET).
BACKGROUND
In addition to anatomic information obtained by coronary CTA, several functional CT parameters have been proposed to identify hemodynamically significant lesions more accurately, such as TAG, TAG-CCO, and more recently TDG. However, clinical validation studies have reported conflicting results, and a recent study has suggested that TAG may be affected by changes in vessel diameter.
METHODS
Patients with suspected coronary artery disease underwent coronary CTA and [
RESULTS
A total of 557 (91.9%) coronary arteries of 201 patients were included for analysis. TAG, TAG-CCO, and TDG did not discriminate between vessels with or without ischemia as defined by either PET or FFR. Furthermore, these parameters did not have incremental diagnostic accuracy over coronary CTA alone for the presence of ischemia as defined by PET and FFR. There was a significant correlation between TDG and TAG (r = 0.47; p < 0.001) and between TDG and TAG-CCO (r = 0.37; p < 0.001).
CONCLUSIONS
TAG, TAG-CCO, and TDG do not provide incremental diagnostic value over coronary CTA alone for the presence of ischemia as defined by [

Identifiants

pubmed: 29248645
pii: S1936-878X(17)30990-7
doi: 10.1016/j.jcmg.2017.10.009
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-333

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Michiel J Bom (MJ)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Roel S Driessen (RS)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Wynand J Stuijfzand (WJ)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Pieter G Raijmakers (PG)

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.

Cornelis C Van Kuijk (CC)

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.

Adriaan A Lammertsma (AA)

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.

Albert C van Rossum (AC)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Niels van Royen (N)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Juhani Knuuti (J)

Turku University Hospital and University of Turku, Turku, Finland.

Maija Mäki (M)

Turku University Hospital and University of Turku, Turku, Finland.

Koen Nieman (K)

Department of Cardiovascular Medicine and Department of Radiology, Stanford School of Medicine, Palo Alto, California.

James K Min (JK)

Institute for Cardiovascular Imaging, Weill-Cornell Medical College, New York-Presbyterian Hospital, New York, New York.

Jonathon A Leipsic (JA)

Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada.

Ibrahim Danad (I)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands.

Paul Knaapen (P)

Department of Cardiology, VU University Medical Center, Amsterdam, the Netherlands. Electronic address: p.knaapen@vumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH